There are a lot of risk factors which are believed to have a role in disease progression, such as age at the time of initial presentation, tumor stage, histology and ploidy of tumor, and cytogenetic aberrations including MYCN amplification, loss of heterozygosity of 1p and 11q, and 17q gain (1,2). The gene discussed is MYCN; the disease is neoplasm.